Blog
EQS-News: Management handover at M+M Software SE
EQS-News: Management handover at M+M Software SE
EQS-News: Daldrup & Söhne AG receives drilling order from the City of Frankfurt to explore the local geology
EQS-News: Daldrup & Söhne AG receives drilling order from the City of Frankfurt to explore the local geology
EQS-News: CompuGroup Medical takes data strategy to an international level by acquiring 20 percent stake in New Line
EQS-News: CompuGroup Medical takes data strategy to an international level by acquiring 20 percent stake in New Line
EQS-News: Deutsche Beteiligungs AG: Completion of the generation change on the Board of Management
EQS-News: Deutsche Beteiligungs AG: Completion of the generation change on the Board of Management
EQS-News: Continentale Versicherungsverbund relies on adesso standard products for the modernisation of its application landscape
EQS-News: Continentale Versicherungsverbund relies on adesso standard products for the modernisation of its application landscape
EQS-Adhoc: Deutsche Beteiligungs AG (ISIN: DE000A1TNUT7 / WKN: A1TNUT) – Changes in the Board of Management of Deutsche Beteiligungs AG
EQS-Adhoc: Deutsche Beteiligungs AG (ISIN: DE000A1TNUT7 / WKN: A1TNUT) – Changes in the Board of Management of Deutsche Beteiligungs AG
Allane Mobility Group: Short-term leasing as a favorable alternative to car subscription – VW T-Cross for commercial customers incl. insurance now also available with twelve-month term
Allane Mobility Group: Short-term leasing as a favorable alternative to car subscription – VW T-Cross for commercial customers incl. insurance now also available with twelve-month term
SThree: Notice of Second Investor Briefing
SThree: Notice of Second Investor Briefing
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: HENSOLDT AG accelerates growth and raises targets
Custodian Property Income REIT plc: Interim Results
Custodian Property Income REIT plc: Interim Results
Dalata Hotel Group PLC: Trading Update: Trading ahead of expectations
Dalata Hotel Group PLC: Trading Update: Trading ahead of expectations
TUI AG: Annual Financial Report - Part 2
TUI AG: Annual Financial Report - Part 2
SThree: FY 2022 Trading Update
SThree: FY 2022 Trading Update
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
EQS-News: Fourteenth acquisition in 2022: Mutares signs agreement to acquire Palmia Oy from the City of Helsinki
EQS-News: Fourteenth acquisition in 2022: Mutares signs agreement to acquire Palmia Oy from the City of Helsinki
Holcim divests business in Russia
Holcim divests business in Russia
Evolva launches its Natural Nootkatone
Evolva launches its Natural Nootkatone
Relief Therapeutics to Participate in January Investor Meetings
Relief Therapeutics to Participate in January Investor Meetings
Cosmo announces successful Phase III clinical trial of Lumeblue™ in China
Cosmo announces successful Phase III clinical trial of Lumeblue™ in China
EQS-News: Epigenomics Releases Performance Data on Next Generation Test
EQS-News: Epigenomics Releases Performance Data on Next Generation Test
EQS-News: Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer Test
EQS-News: Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer Test
EQS-Adhoc: Epigenomics Releases Performance Data on Next Generation Test
EQS-Adhoc: Epigenomics Releases Performance Data on Next Generation Test
EQS-Adhoc: Allterco JSCo: Resolutions of Extraordinary General Meeting
EQS-Adhoc: Allterco JSCo: Resolutions of Extraordinary General Meeting
EQS-News: va-Q-tec and EQT Private Equity agree strategic partnership
EQS-News: va-Q-tec and EQT Private Equity agree strategic partnership
EQS-Adhoc: va-Q-tec AG: Conclusion of a Business Combination Agreement with EQT Private Equity and approval of a cash capital increase without subscription rights of approx. 10% of the share capital
EQS-Adhoc: va-Q-tec AG: Conclusion of a Business Combination Agreement with EQT Private Equity and approval of a cash capital increase without subscription rights of approx. 10% of the share capital


